NOW ENROLLING: CANaspire, Aspa’s investigational gene therapy trial for patients with Canavan disease.
Families can visit www.treatcanavan.com to learn more or click here to register interest.

Aspa Therapeutics, a BridgeBio company, shares an update on the CANinform natural history study. Details can be found here.